Mindmed to host earnings call to discuss full-year 2021 financial results and provide business update

New york , march 21, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host its earnings call on monday, march 28, 2022, at 8:30 a.m. edt to discuss its financial results for the full year ended december 31, 2021 and provide a business update.
MNMD Ratings Summary
MNMD Quant Ranking